Dear WeFunder Friends,

By now you all know quite a bit about VirZOOM from the material on our WeFunder page and updates. But there’s a lot more to the VirZOOM story than we can tell here without revealing confidential information to the public that the company needs to protect.

In particular, VirZOOM has developed since early 2015 and plans to continue to evolve in multiple stages into a business model that has been called “Peloton on Steroids” by more than one venture firm that has reviewed it.

If the company is able to complete its evolution to maturity, the company can potentially generate hundreds of millions in revenue monthly at better than 80% gross margins by operating according to this business model.

We cannot, for obvious reasons, publish the blueprint for such a revolutionary business model on the Internet, but we think it’s important that investors and prospective investors have the opportunity to learn about it. We will review and discuss it in detail with investors and followers next week in a VirZOOM WeFunder NDA Webinar series under VirZOOM’s non-disclosure agreement (NDA), starting next Monday.

VirZOOM WeFunder NDA Webinar Schedule
Dec. 17: 11AM EST
Dec. 17: 2PM EST
Dec. 18: 11AM EST
Dec. 18: 2PM EST
Dec. 19: 11AM EST
Dec. 19: 2PM EST

These webinars will not be recorded. You need to attend if you want to learn more. And you will have the opportunity to ask me questions directly and take part in a lively conversation about the company and its plans.

If you’d like to attend, please send an email to indicate a day and time to: [email protected]

You will receive a VirZOOM Mutual NDA via Docusign that you need to execute before you will receive your invitation to attend.

Thank you for your interest. I'm looking forward to seeing you on a VirZOOM WeFunder NDA Webinar next week.

Best Regards,

Eric Janszen

Co-Founder & CEO

VirZOOM, Inc.